Atea Pharmaceuticals
Earnings Date & Report
Last updated:
Atea Pharmaceuticals’s last earnings date was on 6 Nov 2024.
Atea Pharmaceuticals stock Earnings report, Estimates & History
| 2020-12-10 | -1.05 | -1.74 |
|---|---|---|
| 2021-03-30 | 0.16 | 0.96 |
| 2021-05-13 | -0.05 | 0.34 |
| 2021-08-12 | 0.005 | 0.02 |
| 2021-11-11 | -0.05 | -0.34 |
| 2022-02-28 | 0.17 | 1.34 |
| 2022-05-10 | -0.58 | -0.51 |
| 2022-08-08 | -0.52 | -0.38 |
| 2022-11-07 | -0.44 | -0.1 |
| 2023-02-28 | -0.45 | -0.41 |
| 2023-05-08 | -0.51 | -0.43 |
| 2023-08-08 | -0.47 | -0.34 |
| 2023-11-08 | -0.46 | -0.4 |
| 2024-02-28 | -0.44 | -0.47 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Atea Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 6 Nov 2024 | N/A | N/A | N/A | N/A | N/A | |
| 6 Aug 2024 | N/A | N/A | N/A | N/A | N/A | |
| 13 May 2024 | N/A | -$0.61 | N/A | N/A | N/A | Earnings Call Transcript |
| 28 Feb 2024 | Missed | -$0.44 | -$0.47 | N/A | N/A | Earnings Call Transcript |
| 8 Nov 2023 | Beat | -$0.46 | -$0.4 | N/A | N/A | Earnings Call Transcript |
| 14 Aug 2023 | N/A | -$0.47 | N/A | N/A | N/A | |
| 8 Aug 2023 | Beat | -$0.47 | -$0.34 | N/A | N/A | Earnings Call Transcript |
| 8 May 2023 | Beat | -$0.51 | -$0.43 | N/A | N/A | Earnings Call Transcript |
| 28 Feb 2023 | Beat | -$0.45 | -$0.41 | N/A | N/A | Earnings Call Transcript |
| 7 Nov 2022 | Beat | -$0.44 | -$0.1 | N/A | N/A | Earnings Call Transcript |
| 8 Aug 2022 | Beat | -$0.52 | -$0.38 | N/A | N/A | Earnings Call Transcript |
| 10 May 2022 | Beat | -$0.58 | -$0.51 | 85.73M | 192.18M | Earnings Call Transcript |
| 28 Feb 2022 | Beat | $0.17 | $1.34 | 85.73M | 192.18M | Earnings Call Transcript |
| 11 Nov 2021 | Missed | -$0.05 | -$0.34 | 141.74M | 32.81M | Earnings Call Transcript |
| 12 Aug 2021 | Beat | $0.01 | $0.02 | 60.39M | 60.39M | Earnings Call Transcript |
| 13 May 2021 | Beat | -$0.05 | $0.34 | 522.60M | 65.98M | Earnings Call Transcript |
| 30 Mar 2021 | Beat | $0.16 | $0.96 | N/A | 48.63M | |
| 10 Dec 2020 | Missed | -$1.05 | -$1.74 | N/A | 48.63M | |
| 30 Jun 2020 | N/A | N/A | -$0.21 | N/A | N/A | |
| 31 Mar 2020 | N/A | N/A | -$0.08 | N/A | N/A | |
Atea Pharmaceuticals Earnings report FAQs
When is Atea Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Atea Pharmaceuticals's earnings date was on 8 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.